Citation Impact
Citing Papers
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Functional diversity of helper T lymphocytes
1996 StandoutNature
Immunobiology of eosinophils in allergy and inflammation
1997
Eosinophil chemotactic activity of topical PAF on the human nasal mucosa
1992
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Inducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia
1997 StandoutNobel
Local Cellular and Humoral Responses to Antigenic and Distilled Water Challenge in Subjects with Allergic Rhinitis
1988
Chemokines and leukocyte traffic
1998 StandoutNature
Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease—insights and potential therapeutic implications
2007
A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP
1991 Standout
Asthma Genetics
2002
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
α‐Galactosylceramide‐induced iNKT cells suppress experimental allergic asthma in sensitized mice: Role of IFN‐γ
2005
Ibuprofen-like activity in extra-virgin olive oil
2005 StandoutNature
Eosinophil function in health and disease
1995
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
The New Topical Steroid Ciclesonide Is Effective in the Treatment of Allergic Rhinitis
1999
Cytokines in asthma
1999
Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction
1989
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
2009 StandoutNature
Facilitatory and inhibitory transmitters modulate calcium influx during action potentials in Aplysia sensory neurons
1990 StandoutNobel
TH2 Cytokines and Allergic Challenge Induce Ym1 Expression in Macrophages by a STAT6-dependent Mechanism
2002
Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin
1988
Cetirizine
1993
Asthma therapy and airway remodeling
2007
The eosinophil and bronchial asthma: Current understanding
1990
Understanding the pathogenesis of allergic asthma using mouse models
2001
Platelet Activation and Atherothrombosis
2007 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
2001 StandoutNature
Use of nasal steroids in managing allergic rhinitis
1999
The development of allergic inflammation
2008 StandoutNature
The pathophysiologic role of alpha 4 integrins in vivo.
1994
Necrotizing Enterocolitis
2011 Standout
Receptors for a growing family of secreted phospholipases A2
1999
Asthma
2001 Standout
Evidence of PAF-acether Metabolic Pathway Activation in Antigen Challenge of Upper Respiratory Airways
1989
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 Standout
[16] Animal models of asthma: Role of chemokines
1997
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus
1991
The Pathophysiology and Treatment of Sepsis
2003 Standout
Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
1997
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Atherosclerosis
2000 StandoutNature
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
Eosinophils: Biology and Role in Disease
1995
Therapeutic approaches to asthma based on VLA-4 integrin and its counter receptors
1995
Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: Effect of topical corticosteroids
1998
The link between the nose and lung, perennial rhinitis and asthma—is it the same disease?
1997
Eosinophils generate brominating oxidants in allergen-induced asthma
2000
Biologic activities of IL-1 and its role in human disease
1998
Incidence and Outcomes of Acute Lung Injury
2005 Standout
Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis
1999
The Epidemiology of Sepsis in the United States from 1979 through 2000
2003 Standout
Homocysteine and Atherothrombosis
1998 Standout
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
cPLA2 is phosphorylated and activated by MAP kinase
1993 Standout
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
1993
Rapid Increase in Bone-marrow Eosinophil Production and Responses to Eosinopoietic Interleukins Triggered by Intranasal Allergen Challenge
1997
Effect of Inhaled Interleukin-5 on Airway Hyperreactivity and Eosinophilia in Asthmatics
1998
Characterization of the Integrin and Activation Steps Mediating Human Eosinophil and Neutrophil Adhesion to Chronically Inflamed Airway Endothelium
1999
Can a Ketone Be More Reactive than an Aldehyde? Catalytic Asymmetric Synthesis of Substituted Tetrahydrofurans
2018 StandoutNobel
Pathophysiological mechanisms of sudden death induced by platelet activating factor
1984
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Ether-phospholipid composition in neutrophile and platelets
1985
Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics
1999
Hazardous air pollutants and asthma.
2002
Shock and Tissue Injury Induced by Recombinant Human Cachectin
1986 StandoutScienceNobel
Inositol trisphosphate, a novel second messenger in cellular signal transduction
1984 StandoutNature
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
The Cells of the Allergic Response
1997
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis
2001
Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils.
1992
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
1996
A genome-wide analysis of immune responses in Drosophila
2001 StandoutNobel
The effect of indomethacin on the contractile response of the guinea‐pig lung parenchymal strip to leukotrienes B4, C4, D4 and E4
1983 StandoutNobel
Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil Function
1985 StandoutNobel
The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.
1984
Anaphylactic sensitization to aeroantigen during respiratory virus infection
1998
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.
1984
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
2004 Standout
Role of Group II Secretory Phospholipase A2in Atherosclerosis
1999
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
2006 StandoutNobel
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
How is the level of free arachidonic acid controlled in mammalian cells?
1982
A Randomized Trial of Protocol-Based Care for Early Septic Shock
2014 Standout
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Is platelet activating factor (PAF) a mediator of endotoxin shock?
1985
The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system
1990
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.
1994
Interleukin-13: Central Mediator of Allergic Asthma
1998 StandoutScience
Influenza Virus–induced Dendritic Cell Maturation Is Associated with the Induction of Strong T Cell Immunity to a Coadministered, Normally Nonimmunogenic Protein
2003 StandoutNobel
The Halogen Bond
2016 Standout
Goblet Cell Density of the Inferior Turbinates in Patients with Perennial Allergic and Nonallergic Rhinitis
1997
Short‐term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T‐cell responses, in patients with allergic rhinitis
1999
RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium
2001
An arachidonoyl (polyenoic)-specific phospholipase A2 activity regulates the synthesis of platelet-activating factor in granulocytic HL-60 cells.
1990
Intracellular Antimicrobial Activity in the Absence of Interferon-γ: Effect of Interleukin-12 in Experimental Visceral Leishmaniasis in Interferon-γ Gene-disrupted Mice
1997
On the expression of nitric oxide synthase by human macrophages. Why no NO?
1995
The Pathogenesis of Sepsis
1991
Intranasal Fluticasone Propionate
1997
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
2003
Works of B.B. Vargaftig being referenced
Pharmacological modulation of Paf‐induced rat pleurisy and its role in inflammation by zymosan
1989
A Genome-Wide Screen for Asthma-Associated Quantitative Trait Loci in a Mouse Model of Allergic Asthma
1999
From lung hypersensitivity to bronchial hyperreactivity
1993
Skin eosinophilia in atopic patients
1988
Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs.
1991
Modulation by rm Interferon‐γ and CD4+ T‐Lymphocytes of Allergic Eosinophil Accumulation in the Mice Peritoneal Cavitya
1994
Involvement of platelet-activating factor in death following anaphylactic shock in boosted and in unboosted mice
1993
Do glucocorticoids enhance eosinopoiesis?
2000
Exacerbated Th2‐mediated airway inflammation and hyperresponsiveness in autoimmune diabetes‐prone NOD mice: a critical role for CD1d‐dependent NKT cells
2004
Murine models of asthma
2003
Demonstration of the Therapeutic Potential of Non-Anaphylactogenic Anti-IgE Antibodies in Murine Models of Skin Reaction, Lung Function and Inflammation
1997
Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
1998
In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs.
1996
Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs.
1994
Eosinophil Recruitment into Guinea Pig Lungs after PAF-acether and Allergen Administration: Modulation by Prostacyclin, Platelet Depletion, and Selective Antagonists
1988
Characterization and pharmacological modulation of antigen‐induced peritonitis in actively sensitized mice
1993
Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80
1992
Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients
1995
Leukotrienes Mediate Murine Bronchopulmonary Hyperreactivity, Inflammation, and Part of Mucosal Metaplasia and Tissue Injury Induced by Recombinant Murine Interleukin-13
2003
Stimulation of early eosinophil progenitors by a heat stable alveolar macrophage product from ovalbumin‐sensitized and non‐sensitized guinea pigs
1997
Platelet-Activating Factor (PAF-acether): Molecular Aspects of Its Release and Pharmacological Actions
1981
Inhibition by aspirin of bronchoconstriction due to leukotrienes C4 and D4 in the guinea pig
1981
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat
1987
Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked
1985
Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea-pig
1982
Selective Mycobacterium avium–induced production of nitric oxide by human monocyte-derived macrophages
1994
Platelet‐Activating Factor (PAF‐Acether) Secretion from Platelets: Effect of Aggregating Agents
1980
Dissociation of platelet activation from transmethylation of their membrane phospholipids
1981 Nature
Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis.
1997
PAF-acether today—Relevance for acute experimental anaphylaxis
1987
Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat
1987
Biosynthesis of platelet-activating factor (PAF-acether) II. Involvement of phospholipase A2 in the formation of PAF-acether and lyso-PAF-acether from rabbit platelets
1982
Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs
1986
What can we learn from murine models of asthma?
1999
Platelet-activating factor (PAF-acether): Thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action
1982
What can we learn from murine models of asthma?
1999
Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways.
1994